solution by MARKET
Pharmaceutical Production Lines & Turnkey Factory Solutions for Uzbekistan
From IV solution lines and OSD plants to injectable filling systems and cleanroom engineering — GMP-compliant manufacturing infrastructure built for Central Asia’s largest and fastest-growing pharmaceutical market.
A Clear View of the Local Market Landscape
The volume of Uzbekistan’s pharma market ($2.136 billion in MAT/08/2025) has surpassed that of Kazakhstan, reflecting Uzbekistan’s larger population and growing demand — strengthening the country’s position as the largest pharmaceutical market in Central Asia. In just January–August 2025, over $290 million was invested in the industry, of which $262.7 million were foreign investments. However, although the share of local products in this market is 40–45 percent in physical volume, in monetary terms it does not exceed 20 percent, underscoring the enormous opportunity for manufacturers investing in new GMP production capacity. Up to 80% of the annual demand for pharmaceutical products in the next five years is targeted to be provided by local production, creating massive demand for production lines, cleanroom systems, and complete factory infrastructure.
Demand Trends Within the Country
-
Pharmaceutical Manufacturing Localization
The government is encouraging localization of production, offering incentives (such as tax and customs benefits in pharmaceutical free economic zones) and reserving 20% of state procurements for domestic companies’ products. This drives urgent demand for new factory builds. -
Injectable & IV Solution Production
With a population of ~35 million and rising healthcare spending, Uzbekistan critically needs locally produced IV fluids, injectable antibiotics, insulin, and vaccines to reduce its heavy import dependence. -
OSD & Generic Drug Manufacturing
Rx-drugs prevail in the structure of retail sales, and affordable generic tablet and capsule production is the highest-priority investment to serve domestic demand and neighboring CIS export markets. -
GMP Compliance & Regulatory Upgrading
From January 1, 2026, all pharmaceutical manufacturers will be required to obtain a national GMP certificate to register their products in Uzbekistan — without proof of compliance, registering new drugs or renewing certificates will be impossible.
Local Experience, Reliable Execution
-
Proven Central Asia delivery track record — 2,500+ production lines deployed in 60+ countries, with extensive project experience across CIS and Central Asian pharmaceutical markets.
-
GMP alignment for Uzbekistan’s new requirements — All systems pre-engineered to meet EU GMP, US FDA cGMP, WHO GMP, and PIC/S GMP standards — positioning clients ahead of Uzbekistan’s mandatory GMP certification requirement effective January 2026.
-
Full turnkey EPC capability — From consulting and process design through equipment manufacturing, cleanroom construction, utility installation, IQ/OQ/PQ validation, technology transfer, and operator training — one partner, one contract.
-
Customized for Uzbekistan’s strategic priorities — Solutions tailored for import substitution, Tashkent Pharma Park and FEZ investments, and regional export ambitions targeting EAEU, Southeast Asia, and Middle East markets.
Selected Products for This Market
-
Online Dilution & Online Dosing Equipment
Product Detail Introduction A large amount of buffers are needed in the downstream purification process of biopharmaceuticals. The accuracy and reproducibility of the buffers have a great impact on the protein purification process. The online dilution and online dosing system can combine a variety of single-component buffers. The mother liquor and the diluent are mixed… -
Clean Room
Introduction lVEN clean room system provides whole-process services covering the design, production, installation and commissioning in purification air conditioning projects strictly in accordance with the relevant standards and ISO/GMP international quality system. We have established construction, quality assurance, experimental animal and other production and research departments. Therefore, we can meet the purification, air conditioning, sterilization,…
Meeting Local Standards with Reliable Delivery
Compliance & Certification
Logistics & Delivery
Success Snapshot
-
Pharmaceutical Manufacturer
Delivered an integrated OSD production plant including tablet and capsule lines, purified water system, cleanroom, and blister packaging within a pharmaceutical free economic zone. The facility obtained national GMP certification and achieved annual output of 400 million tablets and 100 million capsules, enabling the client to serve the domestic market and export to three neighboring CIS countries.
-
Healthcare Investment Group
Supplied a PP bottle IV solution production line with pharmaceutical water system, cleanroom, and automated packaging. The project was completed in 14 months and passed GMP inspection, producing 15 million bottles of IV solution annually and contributing directly to the national localization program.
Trusted by Local Customers
-
“IVEN delivered our complete OSD factory — from equipment and cleanroom to water system and packaging — under one turnkey contract. Their understanding of Uzbekistan’s evolving GMP standards meant we were certified ahead of schedule and exporting to Kazakhstan within the first year.”
Mr. R
General Director
-
“Their IV solution line has been running with excellent reliability since commissioning. The technology transfer program was thorough — our operators were fully independent within weeks. IVEN is a trusted partner for Central Asian pharmaceutical projects.”
Dr. K
Chief Engineer
FAQ
Related Market Solutions
Pharmaceutical Production Lines & Turnkey Factory Solutions for Russia
From IV solution filling lines and OSD plants to injectable systems, biologics equipment, and cleanroom engineering — GMP-compliant manufacturing infrastructure built to support Russia’s Pharma 2030 import substitution and full-cycle localization strategy.
